Cellceutix (CTIX) Release: Coach Jim Boeheim Putting Up His Best Defense Against Michigan... and Cancer
4/5/2013 9:28:28 AM
More...
|
Cellceutix (CTIX) Selected for Poster Presentation on Kevetrin at 2013 American Society of Clinical Oncology Meeting
4/1/2013 8:54:14 AM
More...
|
Cellceutix (CTIX) Plans for Future Trials Aimed at the Latest Initiatives of "Breakthrough" Designation by the FDA
3/11/2013 9:42:14 AM
More...
|
Cellceutix (CTIX) Signs With Leading Cancer Center for Licensing New Drug
3/4/2013 9:34:21 AM
More...
|
Cellceutix (CTIX) Reports on Kevetrin Clinical Trials and Prurisol Manufacturing
2/25/2013 9:59:04 AM
More...
|
Cellceutix (CTIX) Abstract for Annual American Society of Clinical Oncology Meeting
2/4/2013 9:55:37 AM
More...
|
Cellceutix (CTIX) Reports in Vivo Tumor Shrinkage in Renal Cancer
1/24/2013 8:37:56 AM
More...
|
Cellceutix (CTIX) CEO Discusses Corporate Developments in 2012 and Plans for 2013
1/2/2013 8:25:30 AM
More...
|
Cellceutix (CTIX) Comments on New York Times Article Heralding p53 Drugs as the New Age in Cancer Research
12/27/2012 9:52:37 AM
More...
|
Cellceutix (CTIX) Announces Kevetrin Dosing Levels Increased as Clinical Trials Advance
12/14/2012 9:59:19 AM
More...
|
|